<DOC>
	<DOCNO>NCT01513525</DOCNO>
	<brief_summary>This trial conduct Europe . aim trial compare pharmacokinetic profile liraglutide administration thigh versus abdomen administration upper arm versus abdomen .</brief_summary>
	<brief_title>Comparison Liraglutide Injected Three Different Injection Sites Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Liraglutide</mesh_term>
	<criteria>Healthy Good general health judge Investigator base medical history , physical examination include 12lead ECG ( electrocardiogram ) , vital sign blood urinary laboratory assessment BMI ( Body Mass Index ) : 18.527.5 kg/m^2 , inclusive Known suspect allergy trial product ( ) relate product Females childbearing potential pregnant , breastfeed intend become pregnant use adequate contraceptive method require local law practice The receipt investigational drug within 3 month prior trial History clinically significant renal , hepatic , cardiovascular , pulmonary , gastrointestinal , metabolic , endocrine , haematological , neurological , psychiatric disease major disorder may interfere objective trial , judge Investigator Impaired renal function Active hepatitis B and/or active hepatitis C Positive human immunodeficiency virus ( HIV ) antibody Use prescription nonprescription medication , except paracetamol vitamin History alcoholism drug abuse last 12 month . Smoking Habitual excessive consumption methylxanthinecontaining ( theophylline , caffeine theobromine ) beverages food ( coffee , tea , soft drink red bull , cola , chocolate ) judge Investigator Excessive consumption diet deviate normal diet judge Investigator Blood donation within last 3 month Plasma donation within last month</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>